UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - IVERIC BIO INC ownership

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of IVERIC BIO INC
ValueSharesWeighting
Q2 2023$12,141,8370.0%499,0480.0%0.01%0.0%
Q1 2023$12,141,837
+375.0%
499,048
+318.0%
0.01%
+500.0%
Q4 2022$2,556,288
-99.9%
119,397
+7.8%
0.00%0.0%
Q3 2022$1,987,878,000
+86.0%
110,807
-0.3%
0.00%0.0%
Q2 2022$1,068,761,000
-33.0%
111,098
+17.1%
0.00%0.0%
Q1 2022$1,596,275,000
+24.2%
94,847
+23.4%
0.00%
Q4 2021$1,284,999,000
+18.6%
76,854
+15.2%
0.00%
Q3 2021$1,083,891,000
+110.9%
66,742
-18.0%
0.00%
Q2 2021$513,887,000
+5.5%
81,440
+3.3%
0.00%
Q1 2021$487,299,000
+22.9%
78,851
+37.4%
0.00%
Q4 2020$396,634,00057,4000.00%
Other shareholders
IVERIC BIO INC shareholders Q2 2024
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,583,786$8,888,0009.40%
Soleus Capital Management, L.P. 1,607,153$5,529,0006.43%
Burrage Capital Management LLC 1,521,382$4,990,0004.91%
VR Adviser, LLC 2,586,537$8,898,0002.41%
Samsara BioCapital, LLC 862,552$2,967,0001.71%
Tamarack Advisers, LP 1,250,000$4,300,0001.63%
Consonance Capital Management LP 3,150,565$10,838,0000.81%
Ghost Tree Capital, LLC 828,459$2,850,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,267,409$7,800,0000.25%
ACUTA CAPITAL PARTNERS, LLC 139,000$478,0000.23%
View complete list of IVERIC BIO INC shareholders